Fresenius Medical Care (NYSE: FMS) reported Q2 EPS of $0.79, $0.36 better than the analyst estimate of $0.43. Revenue for the quarter came in at $1.2 billion versus the consensus estimate of $4.13 billion.

For earnings history and earnings-related data on Fresenius Medical Care (FMS) click here.